Array BioPharma, Inc. To Present At The Leerink Swann & Company Cancer Medicines On The Horizon Conference

BOULDER, Colo., Sept. 14 /PRNewswire-FirstCall/ -- Array BioPharma Inc. (Nasdaq: ARRY - News) today announced that its Chief Executive Officer, Robert E. Conway, will speak at the Leerink Swann & Company Cancer Medicines on the Horizon Conference on September 18 in New York City. The public is welcome to participate in the conference through an audio webcast on the Array BioPharma website.

MORE ON THIS TOPIC